Life and Health Sciences Research Institute, School of Medicine, University of Minho
Braga, Gualtar, 4710-057, Portugal
Location status: Recruiting
Location contact
Mafalda Sousa, M. Sc.
CONTACT
Pedro Morgado, M.D, Ph.D.
CONTACT
NCT Number: NCT05906069
In the current study, the investigators will characterize obsessive-compulsive disorder (OCD) patients and healthy controls with a comprehensive clinical and neuroimaging assessment, focusing on the basic psychological processes related and on the neurobiological underpinnings of emotion regulation (ER). After a baseline assessment, the investigators will implement an internet-based cognitive behavioral therapy (iCBT) protocol and assess its efficacy on the modulation of ER and OCD severity. Specifically, the investigators will (1) examine to what extent the iCBT intervention modulates ER and the associated neurobiological mechanisms and (2) identify candidate biomarkers of successful treatment response.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Braga, Gualtar, 4710-057, Portugal
Location status: Recruiting
Mafalda Sousa, M. Sc.
CONTACT
Pedro Morgado, M.D, Ph.D.
CONTACT
Sixty patients and sixty controls will be recruited at Hospital de Braga, Braga, Portugal (sample size estimated based on a previous systematic review). A power analysis indicated that a sample of 24 individuals per group is adequate to detect an effect size of d=.89, with a Type I error of .05 and a statistical power of .85. A final sample of 30 individuals was defined to account for a 20% dropout rate during the intervention.
All participants will be assessed with a comprehensive psychological and clinical characterization. Following the baseline assessment, OCD patients will be randomly allocated to the intervention (iCBT intervention) or the control group (waiting list). The iCBT intervention will consist of a structured program comprising 10 modules with text and video content, as well as 3 videoconferencing psychotherapy sessions. After the intervention/waiting list, patients will be re-assessed with the clinical and psychological assessment.
In order to characterize the patterns of brain activation in OCD patients during an emotion regulation task in comparison to healthy controls and to identify potential neurobiological markers of symptoms' improvement, a multimodal neuroimaging assessment will also be performed. The task encompasses the presentation of pictures (fearful, neutral and OCD-related stimuli) under two conditions: the instruction to view the pictures naturally ('observe'); or to apply cognitive reappraisal techniques to decrease any negative affective state caused by the stimuli ('regulate'). Fear and OCD-related pictures are presented during both conditions; neutral pictures only during 'observe'. After each stimulus, the level of distress will be assessed by a self-report rating scale.
In the baseline assessment, brain activation patterns (with whole-brain and region of interest approaches) will be compared between OCD and healthy controls in both task conditions. After intervention, emotion regulation ability and the underlying neurobiological mechanisms will be compared between the 'intervention' and 'waiting list' groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention will consist in a structured internet-based intervention with 10 modules that will combine cognitive-behavioral techniques to improve obsessive-compulsive symptoms as well as the emotion regulation ability.
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess obsessive-compulsive symptoms
Time frame: baseline; 4 weeks after beginning intervention/waitlist; 8 weeks after beginning; 12 weeks after beginning intervention/waitlist and immediately after intervention/waitlist
Psychometric scale to assess obsessive-compulsive symptoms
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess anxiety symptoms
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess depression symptoms
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess stress symptoms
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess cognitive regulation and emotional suppression capabilities
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess emotion deregulation
Time frame: immediately before and immediately after intervention/waitlist
Psychometric scale to assess affect
Time frame: baseline; every week during intervention/wait list (up to 14 weeks) and immediately after intervention/waitlist
Psychometric scale to assess symptoms of anxiety, depression and stress
Time frame: baseline
Psychometric scale to assess personality traits
Time frame: immediately after intervention
Psychometric scale to assess treatment adherence
Time frame: baseline
Psychometric scale to assess motivation to change
Contact information is provided by the study sponsor or research team.
Mafalda Sousa, M., Sc.
CONTACT
Pedro Morgado, M.D, Ph.D.
CONTACT
Pedro Morgado
Other
ITreatOCD: Predicting the Efficacy of Internet-based Cognitive Behavioral Therapy from Changes in the Neurobiological Correlates of Emotion Regulation in Obsessive-compulsive Disorder
Acronym: iTREATOCD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05651295
Anxiety, Anxiety Disorders
Columbus, Ohio, United States
View Trial DetailsNCT05712057
Anxiety Disorders, Behavior
Durham, North Carolina, United States
View Trial DetailsNCT00523718
Anxiety Disorders, Compulsive Personality Disorder
New Haven, Connecticut, United States
View Trial DetailsNCT07347405
Anxiety Disorders, Mental Disorders
Tucson, Arizona, United States
View Trial Details